In a recent randomized, double-blind, placebo-controlled clinical trial, Quer supplementation (500 mg/day, P.O for 8 weeks) evidently improved serum total antioxidant capacity (TAC) in postmyocardial infarction patients compared to the placebo group [126]
As awareness of these benefits spreads and patient access improves, the market for GLP-1 receptor agonists is expected to expand
The program offers: One-on-one support from a team of clinicians, including registered dietitians A nutrition plan personalized to fit your unique needs and preferences Behavioral strategies to overcome barriers to weight loss Connected body weight scale and other devices to support and track your progress The Health Optimizer app with helpful guides, recipes, goal setting and much more Patient stories and patient names are presented for illustrative purposes only
Individual factors such as starting weight, activity level, and diet quality all influence the pace of progress
Diabetes & Metabolism Journal, 48(3), 354372